LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

CollPlant Biotechnologies Ltd.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCLGN
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CLGN COVERAGE

What’s moving CollPlant Biotechnologies Ltd. now

Current reporting with the operating signal separated from the noise.

01
Collplant Biotechnologies Ltd.

Collplant Biotechnologies Ltd.

The story matters when it changes CollPlant Biotechnologies Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript

Investors are testing whether CollPlant Biotechnologies Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (CLGN) Q1 2024 Earnings Call Transcript

Investors are testing whether CollPlant Biotechnologies Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript

Investors are testing whether CollPlant Biotechnologies Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2022 Earnings Call Transcript

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2022 Earnings Call Transcript

Investors are testing whether CollPlant Biotechnologies Ltd.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Loewenbaum Lilian S. Increases Position in Collplant Biotechnologies Ltd (CLGN)

Loewenbaum Lilian S. Increases Position in Collplant Biotechnologies Ltd (CLGN)

The story matters when it changes CollPlant Biotechnologies Ltd.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CLGN filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

6-KOfficial SEC filingFiled 2026-07-29 · Period 2026-07-29SEC ↗6-KOfficial SEC filingFiled 2026-07-28 · Period 2026-07-28SEC ↗SCHEDULE 13D/AOfficial SEC filingFiled 2026-07-31SEC ↗SCHEDULE 13D/AOfficial SEC filingFiled 2026-07-27SEC ↗DOfficial SEC filingFiled 2026-07-20SEC ↗424B3Official SEC filingFiled 2026-07-17SEC ↗EFFECTOfficial SEC filingFiled 2026-07-16SEC ↗F-3Official SEC filingFiled 2026-07-09SEC ↗
EARNINGS / QUARTERLY TRACKER

CollPlant Biotechnologies Ltd., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.

Q4

Fourth quarter / full year

SEARCH Q4 COVERAGE →